Factors That May Affect Likelihood For Readmission Among Diabetes Patients

Seena Haines, PharmD, BCACP, FAPhA, FASHP, BC-ADM, CDE, lists some factors that may contribute to the likelihood of a patient with diabetes needing to be readmitted.

Seena Haines, PharmD, BCACP, FAPhA, FASHP, BC-ADM, CDE, lists some factors that may contribute to the likelihood of a patient with diabetes needing to be readmitted.

Related Videos
Related Content

Patient Access to Clinical Pharmacists Can Improve Medication Adherence

February 6th 2023

Pharmacy Focus - Diabetes Care and Management

February 3rd 2023

The Sooner the Better: Why Pharmacies Need a Smarter Pricing System Now

February 6th 2023

Public Health Matters - Importance of Advocacy in Pharmacy

February 2nd 2023

FDA Approves Prophylaxis Treatment to Prevent Attacks of Hereditary Angioedema in Pediatric Patients

February 6th 2023

FDA Approves Pre-Filled Pen for Self-Administration of Tezepelumab-ekko to Treat Asthma

February 6th 2023

Patient Access to Clinical Pharmacists Can Improve Medication Adherence

February 6th 2023

Pharmacy Focus - Diabetes Care and Management

February 3rd 2023

The Sooner the Better: Why Pharmacies Need a Smarter Pricing System Now

February 6th 2023

Public Health Matters - Importance of Advocacy in Pharmacy

February 2nd 2023

FDA Approves Prophylaxis Treatment to Prevent Attacks of Hereditary Angioedema in Pediatric Patients

February 6th 2023

FDA Approves Pre-Filled Pen for Self-Administration of Tezepelumab-ekko to Treat Asthma

February 6th 2023

Patient Access to Clinical Pharmacists Can Improve Medication Adherence

February 6th 2023

Pharmacy Focus - Diabetes Care and Management

February 3rd 2023

The Sooner the Better: Why Pharmacies Need a Smarter Pricing System Now

February 6th 2023

Public Health Matters - Importance of Advocacy in Pharmacy

February 2nd 2023

FDA Approves Prophylaxis Treatment to Prevent Attacks of Hereditary Angioedema in Pediatric Patients

February 6th 2023

FDA Approves Pre-Filled Pen for Self-Administration of Tezepelumab-ekko to Treat Asthma

February 6th 2023
About Us
Advertise
Contact Us
Editorial Staff
Privacy Policy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Clarke Drive
Cranbury, NJ 08512

609-716-7777

© 2023 MJH Life Sciences

All rights reserved.